Tag: BioNTech
BioNTech Partial Clinical Hold: Morgan Stanley’s Incremental Negative Analysis
BioNTech, a leading biotechnology company, recently announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on their Phase...